Catalyst Wire Dossier Catalyst Wire Dossier

Iontophoretic dexamethasone phosphate ophthalmic solution

dexamethasone phosphate ophthalmic solution · Eyegate Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Iontophoretic dexamethasone phosphate ophthalmic solution, covering 2013-03-29 to 2018-07-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis [Phase 3]

See pricing